The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISP
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provides additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on its use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.
Authors
- Klemen Dovč (ORCID: https://orcid.org/0000-0001-9201-2145)
- Jane E. Yardley (ORCID: https://orcid.org/0000-0001-8761-7019)
- Elizabeth A. Davis (ORCID: https://orcid.org/0000-0003-4244-5473)
- Kirsten Nørgaard (ORCID: https://orcid.org/0000-0003-1620-8271)
- Roman Hovorka (ORCID: https://orcid.org/0000-0003-2901-461X)
- Othmar Moser (ORCID: https://orcid.org/0000-0002-1661-0685)
- Julia Katharina Mader (ORCID: https://orcid.org/0000-0001-7854-4233)
- Martin Tauschmann (ORCID: https://orcid.org/0000-0002-2305-2490)
- Tadej Battelino (ORCID: https://orcid.org/0000-0002-0273-4732)
- RÉMI P.R. RABASA-LHORET (ORCID: https://orcid.org/0000-0003-4706-5170)
- Sabine E. Hofer (ORCID: https://orcid.org/0000-0001-6778-0062)
- Peter G. Jacobs (ORCID: https://orcid.org/0000-0001-9897-4783)
- David Norman O'Neal (ORCID: https://orcid.org/0000-0002-0870-4032)
- Chantal Mathieu (ORCID: https://orcid.org/0000-0002-4055-5233)
- Harald Sourij (ORCID: https://orcid.org/0000-0003-3510-9594)
- Bruce A. Buckingham (ORCID: https://orcid.org/0000-0003-4581-4887)
- Gregory P. Forlenza (ORCID: https://orcid.org/0000-0003-3607-9788)
- Peter Adolfsson (ORCID: https://orcid.org/0000-0001-7615-9737)
- Pieter Gillard
- Dessi P. Zaharieva (ORCID: https://orcid.org/0000-0002-9374-8469)
- John Pemberton (ORCID: https://orcid.org/0000-0002-0730-7879)
- Michael Charles Riddell (ORCID: https://orcid.org/0000-0001-6556-7559)
- Richard M. Bracken (ORCID: https://orcid.org/0000-0002-6986-6449)
- Jennifer L. Sherr (ORCID: https://orcid.org/0000-0001-9301-3043)
- Thomas Danne (ORCID: https://orcid.org/0000-0002-8424-3944)
- Nick S. Oliver (ORCID: https://orcid.org/0000-0003-3525-3633)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Innsbruck Medical University (AT)
- University of Ljubljana (SI)
- Oregon Health & Science University (US)
- The University of Melbourne (AU)
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Universität Innsbruck (AT)
- York University (CA)
- Medical University of Graz (AT)
- University of Cambridge (GB)
- Princess Margaret Hospital for Children (AU)
- Government of Western Australia Department of Health (AU)
- Ljubljana University Medical Centre (SI)
- Yale University (US)
- Swansea University (GB)
- Kinderkrankenhaus auf der Bult (DE)
- St Vincent's Hospital Melbourne (AU)
- Breakthrough (US)
- Birmingham Children's Hospital (GB)
- Hallands sjukhus Kungsbacka (SE)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Stanford Medicine (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- Montreal Clinical Research Institute (CA)
- Perth Children's Hospital
- Imperial College London (GB)
- University of Bayreuth (DE)
- Université de Montréal (CA)
- Medical University of Vienna (AT)
- Wellcome Trust (GB)
- University of Gothenburg (SE)
- University of Colorado Denver (US)
- Stanford University (US)
- KU Leuven (BE)
Publication Details
- Journal
- Hormone Research in Paediatrics
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1159/000542287
- Citations
- 4
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Amarin Corporation
- Insulet Corporation
- Dexcom
- KU Leuven
- Novo Nordisk
- Servier
- Roche Diabetes Care
- HLS Therapeutics
- Abbott Diabetes Care
- Daiichi Sankyo Europe